[
    "{\"step_by_step_thinking\": \"To determine if cabozantinib is effective for Hepatocellular Carcinoma, we need to review the available evidence. Cabozantinib is a tyrosine kinase inhibitor that has been approved for the treatment of advanced renal cell carcinoma and medullary thyroid cancer. However, its effectiveness for Hepatocellular Carcinoma needs to be evaluated separately. To answer this question definitively, we need to consider clinical trials, research studies, and expert opinions on the use of cabozantinib in Hepatocellular Carcinoma.\", \"answer_choice\": \"B. no\"}"
]